Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
Lawmakers unveiled their long-awaited $1.7 trillion government funding package on Dec. 20, 2022. As of publishing, it seems likely that a vote on final passage in the U.S. Senate will occur at some point on Dec. 22, with a...more
In October of 2018, Congress passed the SUPPORT for Patients and Communities Act (P.L. 115-271). The comprehensive opioid treatment law passed both chambers of Congress with large bipartisan support and tackled many aspects...more
Editors’ Note: As COVID-19 rips through the country, an often-overlooked population at extraordinarily high risk is the nearly 2 million adults with opioid use disorder (OUD). This group faces a perfect storm of health and...more
In light of the novel coronavirus pandemic, health care practitioners should be aware of relaxed guidelines for prescribing controlled substance. This blog post describes when practitioners can prescribe controlled substances...more
Jerome Adams Calls on Communities To ‘Be Prepared’ and ‘Save A Life’ The opioid epidemic in America is so out of hand that the U.S. surgeon general’s office has issued an advisory: “Be prepared. Get naloxone. Save a life.”...more
Following the July 13 U.S. Senate's passage of Comprehensive Addiction and Recovery Act (CARA), providers, families and communities should evaluate the act's impacts. The reform, S. 524, is viewed as a comprehensive approach...more